SCHEMBL7080309

SCHEMBL7080309

C=COC(=O)C(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL525402 1.00
Trifluoroacetic Acid SCHEMBL30091831 0.86 TSHR (0.33)
SCHEMBL28859298 0.81 SLC7A5 (0.42)
SCHEMBL28859296 0.81 SLC7A5 (0.42)
SCHEMBL14790127 0.81 TSHR (0.34)
SCHEMBL93534 0.79
SCHEMBL19105201 0.79 TSHR (0.39)
SCHEMBL4201386 0.77
SCHEMBL12211509 0.77
SCHEMBL2886770 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO claimed
EP-4355724-A1 SYNTHESIS OF VINYLATED HYDROXY ESTERS WITH APPLICABILITY IN SIGNAL ENHANCED MAGNETIC RESONANCE IMAGING Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2024-04-24 EP disclosed
WO-2022263620-A1 SYNTHESIS OF VINYLATED HYDROXY ESTERS WITH APPLICABILITY IN SIGNAL ENHANCED MAGNETIC RESONANCE IMAGING Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) 2022-12-22 WO disclosed